Revolutionizing Relief: Conventions Psychiatry & Counseling Partners with Apollo and NeuroStar TMS

Published January 26, 2024
Warrenville, IL ( Friday Jan 26, 2024 @ 7:00 AM Eastern —

Conventions Psychiatry & Counseling is delighted to announce its partnership with Apollo and NeuroStar TMS, introducing an innovative treatment option for individuals grappling with depression. Transcranial Magnetic Stimulation (TMS) therapy, a non-invasive procedure, has demonstrated safety and efficacy, providing long-term remission in patients with treatment-resistant depression.

TMS therapy employs a magnet to stimulate specific nerve cells within the brain responsible for mood control. By targeting these areas, the treatment positively influences neurotransmitter levels, resulting in a reduction in depressive symptoms. Unlike traditional treatments, TMS doesn't involve surgery or medication adjustments, presenting a risk-free alternative for patients.

At Conventions Psychiatry & Counseling, a TMS session ranges from 19 to 37 minutes, designed to be non-disruptive with no impact on alertness or memory. Patients can independently drive to and from sessions. Typically, treatment occurs five days a week for 4-6 weeks, optimizing the potential for successful outcomes.

Covered by most insurances, Conventions TMS Therapy offers an accessible solution for individuals seeking relief from treatment-resistant depression. The therapy provides an evidence-based alternative to medications, instilling new hope for those who haven't found success with traditional treatments.

In collaboration with Apollo and NeuroStar TMS, Conventions Psychiatry & Counseling is dedicated to transforming the lives of individuals suffering from treatment-resistant depression through effective and non-invasive TMS therapy.

This press release is distributed by the™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here Revolutionizing Relief: Conventions Psychiatry & Counseling Partners with Apollo and NeuroStar TMS. is a different kind of newswire, built for the way news is consumed today. Created by the founders of PRWeb, combines traditional newswire distribution features with influencer marketing, blockchain technology and machine learning to increase the visibility, engagement and promotion of your news.